| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net loss | -51,771 | -36,034 |
| Depreciation and amortization | 5,252 | 3,301 |
| Stock-based compensation | 15,551 | 10,416 |
| Provision for bad debts | 3,964 | 1,754 |
| Amortization of operating lease right-of-use assets | 902 | 572 |
| Amortization of debt discount and issuance costs | 946 | 610 |
| Deferred income taxes | -6 | 15 |
| Revaluation of contingent royalty obligation payable to evolus founders | -1,870 | -1,763 |
| Other adjustments to operating activities | 731 | 480 |
| Inventories | 15,783 | 4,291 |
| Accounts receivable | 6,717 | 1,781 |
| Prepaid expenses | 1,255 | 1,443 |
| Accounts payable | 8,057 | 3,945 |
| Accrued expenses | -10,318 | -12,835 |
| Operating lease liabilities | -546 | -256 |
| Other operating assets | 2,229 | 3,113 |
| Net cash used in operating activities | -55,092 | -40,423 |
| Purchases of property and equipment | 1,962 | 1,007 |
| Additions to capitalized software | 4,324 | 3,121 |
| Net cash used in investing activities | -6,286 | -4,128 |
| Payment of contingent royalty obligation to evolus founders | 6,202 | 4,416 |
| Proceeds from issuance and modification of debt instruments | 25,000 | 25,000 |
| Payments for debt modification fees and costs | 2,610 | 2,610 |
| Proceeds from follow-on offering | 0 | 0 |
| Payments for offering costs | 0 | 0 |
| Issuance of common stock in connection with incentive equity plan | 1,083 | 1,065 |
| Payment of financing lease obligation | 11 | 7 |
| Net cash provided by financing activities | 17,260 | 19,032 |
| Effect of exchange rates on cash and cash equivalents | 689 | 305 |
| Net increase (decrease) in cash and cash equivalents | -43,429 | -25,214 |
| Cash and cash equivalents at beginning of period | 86,952 | - |
| Cash and cash equivalents at end of period | 43,523 | - |
Evolus, Inc. (EOLS)
Evolus, Inc. (EOLS)